The selectivity of artemisinin-based drugs on human lung normal and cancer cells

Area of Science:

• Pharmacology
• Cell Biology
• Cancer Research

Background:

• Artemisinin-based drugs exhibit anticancer properties, but their selective efficacy against cancer cells remains debated.
• The precise mechanism underlying artemisinin's action on cancer cells is not fully elucidated.

Purpose of the Study:

• To investigate the cytotoxic effects of artemisinin and artesunate on normal human bronchial epithelial (HBE) cells and A549 lung adenocarcinoma cells.
• To clarify the discrepancy regarding the selective anticancer potential of artemisinin-based compounds.

Main Methods:

• Utilized five distinct assays to assess cytotoxicity.
• Evaluated the impact of artemisinin and artesunate on HBE and A549 cell lines.
• Measured intracellular reactive oxygen species (ROS) levels and DNA damage.

Main Results:

• Artemisinin and artesunate demonstrated dose-dependent cytotoxicity in both HBE and A549 cells.
• A slight selectivity towards A549 cancer cells was observed, but significant cytotoxicity occurred in normal HBE cells.
• Both cell types exhibited increased intracellular ROS and DNA damage.

Conclusions:

• Artemisinin and artesunate exert cytotoxic effects on both normal and cancer cells through a common pathway involving ROS-mediated DNA damage.
• The potential side effects on normal cells must be carefully considered during the development of artemisinin-based antitumor therapies.